Cargando…
CX3CR1 in multiple sclerosis
Autor principal: | Rivest, Serge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652969/ https://www.ncbi.nlm.nih.gov/pubmed/26119158 |
Ejemplares similares
-
Pharmacological depletion of microglia alleviates neuronal and vascular damage in the diabetic CX3CR1-WT retina but not in CX3CR1-KO or hCX3CR1(I249/M280)-expressing retina
por: Church, Kaira A., et al.
Publicado: (2023) -
CX3CR1 and malignant progression of glioma
por: Lee, Sungho, et al.
Publicado: (2021) -
The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy
por: Chaudhri, Apoorvi, et al.
Publicado: (2023) -
Cx3cr1 controls kidney resident macrophage heterogeneity
por: Yashchenko, Alex, et al.
Publicado: (2023) -
Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?
por: Cormican, Sarah, et al.
Publicado: (2021)